A detailed history of Glenmede Investment Management, LP transactions in Scholar Rock Holding Corp stock. As of the latest transaction made, Glenmede Investment Management, LP holds 13,335 shares of SRRK stock, worth $504,329. This represents 0.0% of its overall portfolio holdings.

Number of Shares
13,335
Previous 8,781 51.86%
Holding current value
$504,329
Previous $311 Million 99.84%
% of portfolio
0.0%
Previous 0.0%

Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2025

Nov 13, 2025

BUY
$30.12 - $42.86 $137,166 - $195,184
4,554 Added 51.86%
13,335 $498,000
Q2 2025

Aug 14, 2025

BUY
$24.47 - $36.39 $214,871 - $319,540
8,781 New
8,781 $311 Million

Others Institutions Holding SRRK

About Scholar Rock Holding Corp


  • Ticker SRRK
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 51,640,600
  • Market Cap $1.95B
  • Description
  • Scholar Rock Holding Corporation, a biopharmaceutical company, focuses on the discovery and development of medicines for the treatment of serious diseases in which signaling by protein growth factors plays a fundamental role. The company develops Apitegromab, an inhibitor of the activation of latent myostatin that has completed the Phase 3 clini...
More about SRRK
Track This Portfolio

Track Glenmede Investment Management, LP Portfolio

Follow Glenmede Investment Management, LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Glenmede Investment Management, LP, based on Form 13F filings with the SEC.

News

Stay updated on Glenmede Investment Management, LP with notifications on news.